AKT1 and oculocerebrocutaneous syndrome: Mechanistically, combined with KEGG pathways analysis, our data showed that overexpressed LOC102724169 could decrease MYB by attenuating the PI3K/AKT pathway to enhance cisplatin chemosensitivity and exert an anti-tumor effect in OCCS (Figure 5G).